Spinal Muscular Atrophy Foundation - Company Review
Spinal Muscular Atrophy Foundation - Company ReviewSummary
Spinal Muscular Atrophy Foundation (SMAF) is a healthcare foundation that develops research tools. The foundation offers in vitro and in vivo research tools for use by the industry collaborators and research community. It invests in essential drug discovery assets like animal models and in vitro systems to monitor existing drugs and compound libraries. SMAF’s drug discovery assets consist of SMN ELISA, biomarkers, SMA-MAP biomarker panel, in vitro tools, animal models, in vivo testing and others. The foundation collaborates with pharmaceutical and biotech companies. It caters to government agencies, drug companies, academic institutions and advocacy groups. SMAF is headquartered in New York, the US.
This comprehensive company report of Spinal Muscular Atrophy Foundation provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.